Diabetes - Perspectives in Drug Therapy [recurso electrónico] / edited by Mathias Schwanstecher.
Tipo de material:
TextoSeries Handbook of Experimental Pharmacology ; 203Editor: Berlin, Heidelberg : Springer Berlin Heidelberg, 2011Edición: FirstDescripción: XIV, 410 p. online resourceTipo de contenido: text Tipo de medio: computer Tipo de portador: online resourceISBN: 9783642172144Tema(s): Medicine | Human physiology | Toxicology | Internal medicine | Cytology | Biomedicine | Pharmacology/Toxicology | Human Physiology | Cell Biology | Internal Medicine | Molecular MedicineFormatos físicos adicionales: Printed edition:: Sin títuloClasificación CDD: 615 Clasificación LoC:RM1-950Recursos en línea: Libro electrónico
En: Springer eBooksResumen: Every 5 seconds someone somewhere is diagnosed with diabetes, and every 10 seconds someone dies of it. Even worse, worldwide incidence rates still inexorably escalate. Thus, it is pressing to envisage the extent of the diabetes problem and ensure synergistic approaches aiming in alleviation of its ghastly toll. The chapters of this book report cutting-edge research on molecular events in adiposity and type 2 diabetes, thus opening the way for innovative drug-based therapeutic strategies. It addresses all those who wish to keep in touch with recent developments in the field.
| Tipo de ítem | Biblioteca actual | Colección | Signatura | Copia número | Estado | Fecha de vencimiento | Código de barras |
|---|---|---|---|---|---|---|---|
| Libro Electrónico | Biblioteca Electrónica | Colección de Libros Electrónicos | RM1 -950 (Browse shelf(Abre debajo)) | 1 | No para préstamo | 375457-2001 |
Every 5 seconds someone somewhere is diagnosed with diabetes, and every 10 seconds someone dies of it. Even worse, worldwide incidence rates still inexorably escalate. Thus, it is pressing to envisage the extent of the diabetes problem and ensure synergistic approaches aiming in alleviation of its ghastly toll. The chapters of this book report cutting-edge research on molecular events in adiposity and type 2 diabetes, thus opening the way for innovative drug-based therapeutic strategies. It addresses all those who wish to keep in touch with recent developments in the field.
19
